Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 71335-1690

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 71335-1690). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351690)

Label for Oxybutynin Chloride ER 10 mg extended-release tablets by Bryant Ranch Prepack. The label indicates the product is compared to Ditropan XL 10 mg tablets by Ajanta Pharma Limited with a quantity of 30 tablets. It includes storage instructions, a lot number, a barcode, and a National Drug Code (NDC) 71335-1690-1.*

FDA Label Image

Figure1 (Oxybutynin Figure1)

A line graph comparing mean plasma R-oxybutynin concentration (ng/mL) over 24 hours between Oxybutynin Chloride Extended-Release Tablets 10 mg once daily and Oxybutynin 5 mg three times daily (TID). The x-axis represents time in hours, and the y-axis shows mean plasma concentration with error bars for variability.*

FDA Label Image

Figure2 (Oxybutynin Figure2)

A line chart displaying the mean roxybutynin plasma concentration (ng/mL) over time (hours), showing values from 0 to 24 hours. Error bars indicate variability at each time point.*

FDA Label Image

Figure3 (Oxybutynin Figure3)

A horizontal bar chart comparing the effect of Oxybutynin Chloride Extended Release Tablets versus Placebo. The chart shows bars extending along a numerical scale ranging from -40 to 40, with Oxybutynin Chloride's bar extending negatively, and Placebo's bar closer to zero, indicating differences in effect magnitude.*

FDA Label Image

Figure4 (Oxybutynin Figure4)

A vertical scatter plot chart showing data points representing oxybutynin. The x-axis ranges from -40 to 40, with a data point located at approximately -20. The chart appears to illustrate a distribution or range related to oxybutynin extended-release tablets.*

FDA Label Image

Figure5 (Oxybutynin Figure5)

A horizontal error bar chart showing data for Oxybutynin Chloride Extended-Release Tablets and oxybutynin, indicating ranges with labeled markers on a scale from -40 to 40. The chart compares these two items with negative to positive range values.*

FDA Label Image

Oxybutynin-structure (Oxybutynin Structure)

Chemical structure of oxybutynin chloride showing its molecular composition including cyclohexyl, phenyl, ester, alkyne, and amine groups with hydrochloride ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.